immunotherapy in second-line metastatic hcc
Published 6 years ago • 72 plays • Length 3:27Download video MP4
Download video MP3
Similar videos
-
6:39
emerging second-line therapies in hcc
-
2:18
use of immunotherapy for hcc
-
7:13
immunotherapy in hcc
-
3:02
keynote-224: second-line pembrolizumab’s value in hcc
-
3:00
ongoing clinical trials in second-line hcc
-
2:18
dr. ulahannan on immunotherapy in hepatocellular carcinoma
-
5:27
second-line systemic therapy in hcc
-
1:04
dr. singal on the potential for immunotherapy in hcc
-
3:55
the use of immunotherapy in hcc – efficacy and safety
-
1:50
dr. tim f. greten on immunotherapy in hcc
-
5:41
second-line nivolumab in liver cancer
-
5:40
multitargeted tki therapy in metastatic hcc
-
6:03
two options for checkpoint inhibition in hcc
-
2:08
dr. finn on studies of pembrolizumab in hepatocellular carcinoma
-
4:11
second-line treatment for hepatocellular carcinoma
-
2:25
keynote-224: second-line pembrolizumab for advanced hepatocellular carcinoma
-
5:53
underlying cirrhosis in the second-line setting of hcc
-
0:53
dr. abou-alfa on the role of immunotherapy in hcc
-
1:35
dr. el-khoueiry on evolving role of immunotherapy in hcc